Trial NRG-BR007


A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Type: Treatment
Phase: Phase III
Status: Open to Accrual
Treatments: Hormone, Radiation: External
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Diane Ling, M.D.
Other Trial Staff:  Marissa Aldana, Coordinator, Mary Ordaz, D.M., Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Niranjan Bhatt, D.M., Apoorva Vishwanath, D.M., Leslie Guevara, Coordinator, Othesia Glasgow, D.M., Kimberly Arieli, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.